Cancer Cachexia and Dysregulated Phosphate Metabolism: Insights from Mutant p53 and Mutant Klotho Mouse Models

The present perspective article proposes that cachexia, muscle wasting in cancer, is mediated by dysregulated phosphate metabolism and phosphate toxicity that can damage tissues in most major organ systems. A diet high in phosphorus fed to mice deficient in klotho, a cofactor that regulates phosphate metabolism, accelerates aging, sarcopenia, general organ atrophy, kyphosis, and osteoporosis. Similar effects are seen in phenotypes of mutant p53 mice that overexpress the p53 tumor suppressor gene. Although mutant p53 mice do not develop tumors compared to wild-type mice, mutant p53 mice have shorter mean lifespans. Furthermore, tumorigenesis is associated with the sequestration of excessive inorganic phosphate, and dangerous levels of phosphate are released into circulation during tumor lysis syndrome. In total, this evidence implies that tumorigenesis may be a compensatory mechanism that provides protective effects against systemic exposure to dysregulated phosphate metabolism and phosphate toxicity related to cachexia in cancer. Moreover, the hypothetical protection against phosphate toxicity afforded by tumorigenesis also provides an alternate explanation for putative tumor evasion of the immune system. Insights proposed in this perspective paper provide new directions for further research, with potential to develop novel interventions and clinical applications that modify dietary phosphate intake to reduce cachexia in cancer patients.

[1]  M. Zhang,et al.  Association of serum Klotho levels with cancer and cancer mortality: Evidence from National Health and Nutrition Examination Survey , 2022, Cancer medicine.

[2]  S. Cho,et al.  The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment , 2022, Frontiers in Pharmacology.

[3]  Xiaoqiu Wu,et al.  Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research , 2020, Frontiers in Cell and Developmental Biology.

[4]  Ronald B. Brown Breakthrough Knowledge Synthesis in the Age of Google , 2020, Philosophies.

[5]  A. Giordano,et al.  Role of p53 in the Regulation of Cellular Senescence , 2020, Biomolecules.

[6]  S. Advani,et al.  Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials , 2018, BMC Cancer.

[7]  M. Razzaque,et al.  Phosphate toxicity and tumorigenesis. , 2018, Biochimica et biophysica acta. Reviews on cancer.

[8]  M. Muscaritoli,et al.  Cancer-induced muscle wasting: latest findings in prevention and treatment , 2017, Therapeutic advances in medical oncology.

[9]  V. Baracos,et al.  Cancer Cachexia: Beyond Weight Loss. , 2016, Journal of oncology practice.

[10]  D. Young,et al.  Klotho Mice: A Novel Wound Model of Aged Skin , 2014, Plastic and reconstructive surgery. Global open.

[11]  Elfi Furtmueller,et al.  Using grounded theory as a method for rigorously reviewing literature , 2013, Eur. J. Inf. Syst..

[12]  M. Kuro-o Klotho and the Aging Process , 2011, The Korean journal of internal medicine.

[13]  C. Pui,et al.  The tumor lysis syndrome. , 2011, The New England journal of medicine.

[14]  M. Ohnishi,et al.  Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  B. Karlan,et al.  Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer , 2008, Oncogene.

[16]  Stephen N. Jones,et al.  p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.

[17]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[18]  E. Turley,et al.  A new biological framework for cancer research , 1996, The Lancet.

[19]  Guyen,et al.  Mitochondrial reactive oxygen species, endoplasmic reticulum stress and phosphate toxicity in impairment of pancreatic cells , 2016 .

[20]  E. D. Del Fabbro More is better: a multimodality approach to cancer cachexia. , 2010, The oncologist.

[21]  F. López‐Soriano,et al.  Muscle wasting in cancer and ageing: cachexia versus sarcopenia. , 2006, Advances in gerontology = Uspekhi gerontologii.